Home/Filings/4/0001179110-19-008595
4//SEC Filing

Fletcher Robert C. 4

Accession 0001179110-19-008595

CIK 0000861838other

Filed

Jul 10, 8:00 PM ET

Accepted

Jul 11, 5:18 PM ET

Size

5.7 KB

Accession

0001179110-19-008595

Insider Transaction Report

Form 4
Period: 2019-07-09
Fletcher Robert C.
Sr. VP, Bus. Dev. & Strategy
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-07-09+45,50045,500 total
    Exercise: $2.52Exp: 2029-07-09Common Stock (45,500 underlying)
Footnotes (1)
  • [F1]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on July 9, 2019. Twenty-five percent (25%) of the stock option vests and becomes exercisable on July 9, 2020 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeother

Related Parties

1
  • filerCIK 0001508231

Filing Metadata

Form type
4
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 5:18 PM ET
Size
5.7 KB